CYP2C19 and Alzheimer disease: Therefore, modulation of key target proteins (PTGS2, PLA2G4A, and CYP2C19) within the metabolic signaling pathway, which plays roles in AD pathophysiology, using compounds identified from the P. chaba plant extract, could enhance the current treatment options for AD.